ABSTRACT LIST
NC12
Baseline Characteristics and Preliminary Safety from a Multicenter, Safety Surveillance Study of Lecanemab Treatment for Alzheimer’s Disease in Real-World Clinical Practice Using Alzheimer’s Network for Treatment and Diagnostics (ALZ-NET) Registry
Amitabh Dash, Regional Medical Department, Eisai (Singapore) Pte Ltd, Singapore
ABSTRACT
SHORTLISTED POSTER PRESENTATIONS
Oculomotor Abnormalities as Early Indicators of Cognitive Impairment: Preliminary Results from A Pilot Study Using Eye-Tracking and Intelligent Algorithms
Mr Ng Wei Jie, Department of Neurology, National Neuroscience Institute, Singapore
Trends and Gaps in Public Awareness of Genetic Testing for Dementia Risk: Unsupervised Deep Learning of Twitter Posts from 2010 to 2023
Ms Alcey Ang Li Chang, Medicine Academic Clinical Programme Office, Singapore General Hospital, Singapore
Lost for Words
Dr Jinesh Mukesh Shah, Department of Neurology, National Neuroscience Institute (Singapore General Hospital Campus), Singapore
Unexpected Role of STING Regulating Tonic GABAA Inhibition and Cognitive Brain Function
Prof Jin Bong Park, Department of Veterinary Medicine, Seoul National University, South Korea
Visual Cognitive Assessment Test (VCAT): Utility in Detecting Early Dementia in Diverse Language Cohorts
Ms Ong Cui Fann Gwen, Department of Research, National Neuroscience Institute, Singapore
Risk Models for Alzheimer's Disease Progression within 6 to 36 Month
Dr Yang Caishui, School of Systems Science, Beijing Normal University, China
Evaluation of the Performance of the 4A’s Test in Screening for Delirium in an Inpatient Geriatrics Haematology- Oncology Population
Ms Tan Pin Yan, Division of Oncology Nursing, National University Cancer Institute, National University Health System
Comparative Analysis of Single Cell and Single Nuclei RNA Sequencing Reveals Different Cell Type Clusters in Mouse Brain Tissue
Ms Rachael Phoi Leng Lee, Singleron Biotechnologies, Singapore
NOTCH2NLC Trinucleotide Interruptions are Associated with Cognitive Impairment in Neuronal Intranuclear Inclusion Disease (NIID)
Ms Jayne Tan Yi, Department of Research, National Neuroscience Institute, Singapore
Baseline Plasma Neurofilament Light and Phosphorylated Tau 181 Levels Predict Cognitive Decline in APOE4 and Long SNCA Rep1 Carriers in Parkinson’s Disease
Ms Jayne Tan Yi, Department of Research, National Neuroscience Institute, Singapore
Application of Machine Learning Model for Parkinson’s Disease Risk Prediction Using Clinical and Genetic Data
Dr Mar Gonzalez Porta, Department of Bioinformatics, Nalagenetics Pte Ltd, Singapore
Glymphatic Dysfunction and Its Association with Plasma Biomarkers and Cognitive Impairment in Alzheimer’s Dementia and Mild Cognitive Impairment
Ms Nicole Isabella Tan Yi Zhen, Department of Research, National Neuroscience Institute, Singapore
Plasma Phosphorylated Tau 181 Levels Discriminate Mild Cognitive Impairment and Dementia Patients with Cognitive Decline
Ms Jayne Tan Yi, Department of Research, National Neuroscience Institute, Singapore
Community Engagement Programme for Community-dwelling Patients
Mr Lau Leslie, Department of Neurology, National Neuroscience Institute, Singapore
Suboptimal Seizure Control is Associated with Increased Risk of MCI Among Adult Patients with Epilepsy
Mr Wee Jin Chew, Department of Medicine, National University of Singapore, Singapore
Diagnostic Value of Plasma Phosphorylated tau181, pTau181/Tau and pTau181/Aβ42 and Association with Cognition in Alzheimer’s Disease
Ms Nicole Isabella Tan Yi Zhen, Department of Research, National Neuroscience Institute, Singapore
Dementia Awareness Starts with SingHealth Community Hospitals (SCH)
Dr Chan Qiu Hua Catherine, Post Acute and Continuing Care (PACC), SingHealth Community Hospitals, Singapore
Exploring Neurocognitive Performance Across Elderly Adults With and Without Mild Cognitive Impairment and Dementia Using Cluster Analyses
Dr Eric Tan, Memory, Aging and Cognition Centre, National University of Singapore, Singapore
Predicting Conversion From Mild Cognitive Impairment to Dementia Using Neurocognitive Performance: A Machine Learning Analysis
Dr Eric Tan, Memory, Aging and Cognition Centre, National University of Singapore, Singapore
Incorporation of Plasma P-tau181 to Aβ42 Ratio Significantly Improves the Diagnostic Performance of Routine Clinical Assessments in Detecting Brain Amyloid Positivity
Dr Joyce Chong Ruifen, Department of Pharmacology, National University of Singapore, Singapore
What Matters Most to Informal Caregivers of Persons with Dementia? Results from The Application of Deep Learning to Twitter Posts from 2013 to 2022
Ms Alcey Ang Li Chang, Medicine Academic Clinical Programme Office, Singapore General Hospital, Singapore
Examining the Non-linear Effects of Education on Alzheimer’s and Non-Alzheimer’s Disease: Sex-stratified Analysis
Ms Alcey Ang Li Chang, Medicine Academic Clinical Programme Office, Singapore General Hospital, Singapore
Web-based Self-rated AD8 Questionnaire as a Preliminary Tool in Population Screening for Cognitive Impairment
Dr Rebecca Hui Min Hoe, Department of Neurology, National Neuroscience Institute, Singapore
Examining the Measurement Equivalence of Alzheimer’s Disease Centre Neuropsychological Test Battery (Version 3) Across Two Distinct Cultures Amongst Cognitively Normal Individuals
Ms Koay Way Inn, Department of Psychology, Singapore General Hospital, Singapore
ABSTRACT
CALL FOR ABSTRACT
Doctors, researchers, nurses, therapists, allied health professionals, trainees and programme coordinators are invited to submit abstracts related to clinical and research aspects of dementia.
Please visit https://www.nni.com.sg/events/8th-singapore-international-neuro-cognitive-symposium-
for more information.
All abstracts must be submitted electronically.
ABSTRACT SUBMISSION INSTRUCTIONS
Complete the online form for abstract submission. The organising committee will review the abstract submission and inform participant if the abstract is acceptable within 10 working days.
Poster Presentation
Upon confirmed acceptance of abstract, presenters are to submit the poster in soft copy format for the organising committee to upload on the e-display panel at the Symposium.
All poster presenters will need to standby at their own e-display poster panel on either 28 August 2026 or 29 August 2026, from 12.30pm to 1.30pm, for poster presentation.
IMPORTANT DATE
Abstract Submission Closing Date
12 JUN 2026
ABSTRACT SUBMISSION FORM
PRESENTING AUTHOR'S PARTICULARS
Salutation*
Institution*
Mailing Address*
Postal Code*
Contact Number*
Full Name*
Department*
City & State / Province*
Country / Region*
Email*
ABSTRACT INFORMATION
Abstract Title*
Abstract Content*
Text length NOT to exceed 300 words. The text of the abstract should include section headings such as BACKGROUND/AIM, METHODS, RESULTS and CONCLUSION. The section headings should appear in CAPS.
Word Count: 0
CO-AUTHOR(S)' INFORMATION
Presenting Author above does not need to be added as a co-author.
There is no co-author for this abstract.
Name*
Department*
City & State / Province*
Email*
Institution of Affiliation*
Country*
Error Message